Answers are grounded in this paper and cite their sources.
Purpose: To compare short-term risks of laboratory-defined hematologic abnormalities after nonsteroidal anti-inflammatory drug (NSAID) versus acetaminophen initiation in hospitalized children, accounting for selective complete blood count (CBC) testing. Methods: This retrospective active-comparator cohort study included children aged <18 years who initiated systemic NSAIDs or acetaminophen within 24 hours of admission to the Second Qilu Hospital of Shandong University during 2015–2019. The outcome was a qualifying CBC abnormality within 3 days after treatment initiation. A doubly robust estimator for outcome-dependent testing (DR-ODT) modeled treatment assignment, CBC observation, and outcome risk to estimate standardized risks, risk differences (RDs), and risk ratios (RRs). A Bayesian hierarchical model provided a complementary analysis. Results: The primary cohort comprised 2,003 admissions from 1,898 children; 677 admissions (33.8%) had observed CBC outcomes. Standardized 3-day risks were 55.0% under NSAID initiation and 42.8% under acetaminophen initiation (RD, 12.2 percentage points [95% CI, 0.5–20.0 percentage points]; RR, 1.29 [95% CI, 1.01–1.53]). The Bayesian analysis yielded an RD of 8.4 percentage points (95% credible interval, 0.02–16.4). Exploratory analyses showed the largest difference for elevated neutrophil counts, without a consistent cytopenic pattern. Conclusions: NSAID initiation was associated with a higher estimated short-term risk of laboratory-defined CBC abnormalities than acetaminophen initiation. These findings do not establish a specific NSAID-induced hematologic toxicity syndrome and remain vulnerable to residual confounding and treatment-specific informative testing.
No takes yet. Share an insight, caveat, or question.
Duan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: